These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 5785348)

  • 1. Inhibition of in vitro cell migration in experimental allergic encephalomyelitis.
    Rauch HC; Ferraresi RW; Raffel S; Einstein ER
    J Immunol; 1969 Jun; 102(6):1431-6. PubMed ID: 5785348
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed hypersensitivity studies in experimental allergic encephalomyelitis; a comparison of macrophage migration inhibition tests and electrophoretic mobility.
    Hughes D; Caspary EA; Field EJ
    Z Immunitatsforsch Exp Klin Immunol; 1970; 141(1):14-9. PubMed ID: 4251430
    [No Abstract]   [Full Text] [Related]  

  • 3. [Macrophage migration inhibition test (M.I.T) in experimental allergic encephalitis].
    Del rey Calero J; Calbo Torrecillas F; Otero Puime AA; Gonzalez R-Salinas MC
    Rev Sanid Hig Publica (Madr); 1970 Dec; 44(12):1307-18. PubMed ID: 5525220
    [No Abstract]   [Full Text] [Related]  

  • 4. The blastoid transformation of the lymphocytes from experimental allergic encephalomyelitis guinea pigs.
    Nakano K; Nagai Y; Otani S; Tsumita T
    Jpn J Exp Med; 1971 Apr; 41(2):159-62. PubMed ID: 5313764
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclophosphamide treatment of experimental allergic encephalomyelitis in Lewis rats.
    Paterson PY
    J Immunol; 1971 Jun; 106(6):1473-9. PubMed ID: 4996791
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation and characterization of cells infiltrating the spinal cord during the course of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse.
    Allen SJ; Baker D; O'Neill JK; Davison AN; Turk JL
    Cell Immunol; 1993 Feb; 146(2):335-50. PubMed ID: 8174174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on brain antigens. VI. Prevention of experimental allergic encephalomyelitis by a water-soluble spinal cord protein, 1 -SCP.
    MacPherson CF; Yo SL
    J Immunol; 1973 May; 110(5):1371-5. PubMed ID: 4697833
    [No Abstract]   [Full Text] [Related]  

  • 8. Delayed, relapsing experimental allergic encephalomyelitis in mice.
    Lublin FD; Maurer PH; Berry RG; Tippett D
    J Immunol; 1981 Mar; 126(3):819-22. PubMed ID: 7462632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The application of the irradiated hamster test to the study of experimental allergic encephalomyelitis.
    Kornblum J
    J Immunol; 1968 Oct; 101(4):702-10. PubMed ID: 5681650
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental allergic encephalitogenic substance].
    Yonezawa T; Ishihara Y; Nakatani Y; Iizuka R; Mori T
    Shinkei Kenkyu No Shimpo; 1969 Jun; 13(2):346-54. PubMed ID: 5390678
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental allergic encephalomyelitis. Antiserum inhibition of myelination in vitro.
    Bornstein MB; Raine CS
    Lab Invest; 1970 Nov; 23(5):536-42. PubMed ID: 5483885
    [No Abstract]   [Full Text] [Related]  

  • 12. The generation of the relapse in chronic relapsing experimental allergic encephalomyelitis and multiple sclerosis--parallels and differences.
    Suckling AJ; Kirby JA; Wilson NR; Rumsby MG
    Prog Clin Biol Res; 1984; 146():7-12. PubMed ID: 6609376
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis.
    Brosnan CF; Bornstein MB; Bloom BR
    J Immunol; 1981 Feb; 126(2):614-20. PubMed ID: 6256443
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of experimental autoimmune encephalomyelitis with adenylate deaminase from Penicillium lanoso-viride.
    Nikolajeva V; Eze D; Petrina Z; Muiznieks I
    J Autoimmun; 2000 Mar; 14(2):107-13. PubMed ID: 10677241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunopathology of experimental allergic encephalomyelitis. I. Quantitative analysis of inflammatory cells in situ.
    Sobel RA; Blanchette BW; Bhan AK; Colvin RB
    J Immunol; 1984 May; 132(5):2393-401. PubMed ID: 6371137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune effector cells. IV. Induction of experimental allergic encephalomyelitis in Lewis rats without adjuvant.
    Holda JH; Silberg D; Swanborg RH
    J Immunol; 1983 Feb; 130(2):732-4. PubMed ID: 6184402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of immunological tolerance to brain antigens as a means of specific prevention and treatment of experimental allergic encephalomyelitis].
    Reber NV
    Biull Eksp Biol Med; 1971 Nov; 72(11):69-73. PubMed ID: 5131039
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of whole body x-irradiation on experimental allergic encephalomyelitis in the rat.
    Visakorpi R; Kosunen TU
    Ann Med Exp Biol Fenn; 1972; 50(2):95-7. PubMed ID: 5054283
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of myelin antigens in murine relapsing experimental allergic encephalomyelitis.
    Lublin FD
    J Clin Lab Immunol; 1984 Apr; 13(4):179-82. PubMed ID: 6204053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vitro assay for encephalitogenic components of central nervous tissue.
    Brockman JA; Stiffey AV; Tesar WC
    J Immunol; 1968 Jun; 100(6):1230-6. PubMed ID: 5696285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.